Phase 1 Newly Diagnosed Glioblastoma Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1Phase 2

Study of an AAV Mediated Dual-Payload Gene Therapy in Patients With High Grade Glioma

Glioblastoma (GBM)Recurrent GlioblastomaNewly Diagnosed Glioblastoma+1 more

Trogenix ltd68 enrolled2 locationsNCT07346144

Recruiting

Phase 1Phase 2

New Adjuvant Vaccine in Glioblastoma, a Phase 1/2a Study

Newly Diagnosed Glioblastoma

Assistance Publique - Hôpitaux de Paris35 enrolled3 locationsNCT06622434

Recruiting

Phase 1

A Study to Evaluate the Safety of a Stem Cell-Based Gene and Cell Therapy in Patients With Newly Diagnosed Glioblastoma

Glioblastoma (GBM)Newly Diagnosed Glioblastoma Multiforme

CHA University10 enrolled1 locationNCT07143812